115 related articles for article (PubMed ID: 8842123)
1. Primary and secondary infections with Cryptosporidium parvum in immunosuppressed adult mice.
Cheng L; Rasmussen KR; Healey MC; Yang S
Am J Trop Med Hyg; 1996 Sep; 55(3):324-9. PubMed ID: 8842123
[TBL] [Abstract][Full Text] [Related]
2. Effects of dehydroepiandrosterone in immunosuppressed adult mice infected with Cryptosporidium parvum.
Rasmussen KR; Healey MC; Cheng L; Yang S
J Parasitol; 1995 Jun; 81(3):429-33. PubMed ID: 7776129
[TBL] [Abstract][Full Text] [Related]
3. Concurrent response to challenge infection with Cryptosporidium parvum in immunosuppressed C57BL/6N mice.
Surl CG; Kim HC
J Vet Sci; 2006 Mar; 7(1):47-51. PubMed ID: 16434849
[TBL] [Abstract][Full Text] [Related]
4. Effects of dehydroepiandrosterone in immunosuppressed rats infected with Cryptosporidium parvum.
Rasmussen KR; Martin EG; Healey MC
J Parasitol; 1993 Jun; 79(3):364-70. PubMed ID: 8501592
[TBL] [Abstract][Full Text] [Related]
5. Infection of immunosuppressed C57BL/6N adult mice with a single oocyst of Cryptosporidium parvum.
Yang S; Benson SK; Du C; Healey MC
J Parasitol; 2000 Aug; 86(4):884-7. PubMed ID: 10958482
[TBL] [Abstract][Full Text] [Related]
6. Effects of pine bark extract administered to immunosuppressed adult mice infected with Cryptosporidium parvum.
Kim HC; Healey JM
Am J Chin Med; 2001; 29(3-4):469-75. PubMed ID: 11789589
[TBL] [Abstract][Full Text] [Related]
7. Substance P receptor antagonism for treatment of cryptosporidiosis in immunosuppressed mice.
Robinson P; Martin P; Garza A; D'Souza M; Mastrangelo MA; Tweardy D
J Parasitol; 2008 Oct; 94(5):1150-4. PubMed ID: 18576802
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a single dose methylprednisolone acetate immune suppression model using Cryptosporidium muris and Cryptosporidium parvum.
Miller TA; Schaefer FW
Vet Parasitol; 2006 Oct; 141(1-2):66-83. PubMed ID: 16757117
[TBL] [Abstract][Full Text] [Related]
9. Changes in mouse circulating leukocyte numbers in C57BL/6 mice immunosuppressed with dexamethasone for Cryptosporidium parvum oocyst production.
Miller TA; Schaefer FW
Vet Parasitol; 2007 Nov; 149(3-4):147-57. PubMed ID: 17904293
[TBL] [Abstract][Full Text] [Related]
10. Differential intra-epithelial lymphocyte phenotypes following Cryptosporidium parvum challenge in susceptible and resistant athymic strains of mice.
Adjei AA; Jones JT; Enriquez FJ
Parasitol Int; 2000 Aug; 49(2):119-29. PubMed ID: 10882901
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic efficacy of paromomycin in immunosuppressed adult mice infected with Cryptosporidium parvum.
Healey MC; Yang S; Rasmussen KR; Jackson MK; Du C
J Parasitol; 1995 Feb; 81(1):114-6. PubMed ID: 7876965
[TBL] [Abstract][Full Text] [Related]
12. Effects of dexamethasone and dehydroepiandrosterone in immunosuppressed rats infected with Cryptosporidium parvum.
Rasmussen KR; Martin EG; Arrowood MJ; Healey MC
J Protozool; 1991; 38(6):157S-159S. PubMed ID: 1840147
[TBL] [Abstract][Full Text] [Related]
13. Dietary nucleosides and nucleotides reduce Cryptosporidium parvum infection in dexamethasone immunosuppressed adult mice.
Adjei AA; Jones JT; Enriquez FJ; Yamamoto S
Exp Parasitol; 1999 Jul; 92(3):199-208. PubMed ID: 10403761
[TBL] [Abstract][Full Text] [Related]
14. Patent gut infections in immunosuppressed adult C57BL/6N mice following intraperitoneal injection of Cryptosporidium parvum oocysts.
Yang S; Healey MC
J Parasitol; 1994 Apr; 80(2):338-42. PubMed ID: 8158484
[TBL] [Abstract][Full Text] [Related]
15. The immunosuppressive effects of dexamethasone administered in drinking water to C57BL/6N mice infected with Cryptosporidium parvum.
Yang S; Healey MC
J Parasitol; 1993 Aug; 79(4):626-30. PubMed ID: 8331488
[TBL] [Abstract][Full Text] [Related]
16. Supplementation with Lactobacillus reuteri or L. acidophilus reduced intestinal shedding of cryptosporidium parvum oocysts in immunodeficient C57BL/6 mice.
Alak JI; Wolf BW; Mdurvwa EG; Pimentel-Smith GE; Kolavala S; Abdelrahman H; Suppiramaniam V
Cell Mol Biol (Noisy-le-grand); 1999 Sep; 45(6):855-63. PubMed ID: 10541481
[TBL] [Abstract][Full Text] [Related]
17. Profiles of healing and nonhealing Cryptosporidium parvum infection in C57BL/6 mice with functional B and T lymphocytes: the extent of gamma interferon modulation determines the outcome of infection.
Theodos CM; Sullivan KL; Griffiths JK; Tzipori S
Infect Immun; 1997 Nov; 65(11):4761-9. PubMed ID: 9353062
[TBL] [Abstract][Full Text] [Related]
18. Cryptosporidium parvum infection in experimentally infected mice: infection dynamics and effect of immunosuppression.
Tarazona R; Blewett DA; Carmona MD
Folia Parasitol (Praha); 1998; 45(2):101-7. PubMed ID: 9684319
[TBL] [Abstract][Full Text] [Related]
19. Curcumin: A promising treatment for Cryptosporidium parvum infection in immunosuppressed BALB/c mice.
Asadpour M; Namazi F; Razavi SM; Nazifi S
Exp Parasitol; 2018 Dec; 195():59-65. PubMed ID: 30385266
[TBL] [Abstract][Full Text] [Related]
20. Cryptosporidium parvum biliary tract infection in adult immunocompetent and immunosuppressed mice.
Verdon R; Polianski J; Grodet A; Garry L; Carbon C
J Med Microbiol; 1998 Jan; 47(1):71-7. PubMed ID: 9449952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
